NEUVOGEN THERAPEUTICS
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98977356
- Registration number
- 8120880
- Mark type
- Stylized text
- Filed
- 24 Apr 2024
- Published for opposition
- 10 Dec 2024
- Registered
- 27 Jan 2026
- Attorney of record
- Bret J. Danow
Goods and services
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines
Owner
- Neuvogen, Inc., San Diego, CA, US
- Neuvogen, Inc., San Diego, CA, US
- Neuvogen, Inc., San Diego, CA, US
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 02 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Aug 2025 — USE AMENDMENT FILED
- 31 Dec 2025 — DIVISIONAL PROCESSING COMPLETE
- 18 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 30 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 18 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2025 — SOU EXTENSION 1 GRANTED
- 30 Jul 2025 — SOU EXTENSION 1 FILED
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED